|
|
| | (R)-methyl 7-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)- 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1 Basic information |
| Product Name: | (R)-methyl 7-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)- 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1 | | Synonyms: | (R)-methyl 7-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)- 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1;Retagliptin Hydrochloride | | CAS: | 1174038-86-8 | | MF: | C19H19ClF6N4O3 | | MW: | 500.8225792 | | EINECS: | | | Product Categories: | | | Mol File: | 1174038-86-8.mol | ![(R)-methyl 7-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)- 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1 Structure](CAS/20180808/GIF/1174038-86-8.gif) |
| | (R)-methyl 7-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)- 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1 Chemical Properties |
| | (R)-methyl 7-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)- 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1 Usage And Synthesis |
| Uses | Retagliptin (SP2086) hydrochloride is a potent inhibitor of beta-amino acids and dipeptidyl peptidase-4 (DPP-4). Retagliptin (SP2086) hydrochloride inhibits type 2 diabetes and improves glycemic control by prolonging the action of intestinal hormones such as glucagon-like peptide-1 (GLP-1)[1]. | | References | [1] Kim GH, et al. Enzymatic synthesis of sitagliptin intermediate using a novel ω-transaminase. Enzyme Microb Technol. 2019 Jan;120:52-60. DOI:10.1016/j.enzmictec.2018.10.003 |
| | (R)-methyl 7-(3-amino-4-(2,4,5-trifluorophenyl)butanoyl)-3-(trifluoromethyl)- 5,6,7,8-tetrahydroimidazo[1,5-a]pyrazine-1 Preparation Products And Raw materials |
|